+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Typing Intermediates Market by Product Type (Product Type), Application (Application), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Blood Typing Intermediates Market by Product Type (Product Type), Application (Application), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Blood Typing Intermediates Market by Product Type (Product Type), Application (Application), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6119034
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Blood typing intermediates constitute the essential reagents, enzymes, antibodies, and testing components that underpin the accuracy and reliability of immunohematological diagnostics. As transfusion procedures, prenatal screenings, and therapeutic monitoring become increasingly sophisticated, the demand for precision in ABO and Rh blood grouping has never been more critical. Molecular techniques, serological assays, and high-throughput automation depend on a consistent supply of high-quality intermediates, which serve as the foundation for effective patient care and clinical decision-making.

Understanding the evolving needs of clinical laboratories, blood banks, hospitals, and research institutions highlights the vital role these intermediates play in ensuring compatibility, reducing adverse transfusion events, and advancing immunohematology research. Concurrently, the integration of novel monoclonal and polyclonal antibody technologies, alongside enhanced enzyme formulations, is driving significant enhancements in specificity and sensitivity. This confluence of clinical demand and technological progression establishes the blood typing intermediates landscape as a focal point for innovation, investment, and cross-disciplinary collaboration.

Uncovering the Transformative Shifts Redefining Blood Typing Intermediates as Innovation and Regulation Drive Market Evolution

Recent developments in assay automation, data analytics, and next generation antibody engineering are reshaping the blood typing intermediates landscape at an unprecedented pace. Platforms that integrate digital readouts with serological workflows are streamlining laboratory operations and reducing manual variability. Meanwhile, advancements in monoclonal antibody design, including targeted isotype enhancements, are delivering greater specificity for complex blood group antigens. These technological innovations are enabling laboratories to achieve faster turnaround times, heightened throughput, and elevated levels of standardization.

In parallel, regulatory frameworks are evolving to address the safety and traceability of biological reagents, with enhanced guidelines around quality management, lot-to-lot consistency, and post-market surveillance. Manufacturers are adapting by adopting rigorous validation protocols and pursuing certifications that align with international standards. The combined effect of cutting-edge research, clinical demands for precision, and tighter regulatory oversight is driving a transformative shift toward a more integrated, efficient, and quality-driven ecosystem for blood typing intermediates.

Evaluating the Cumulative Impact of United States Tariffs on Blood Typing Intermediates by 2025 Across Supply Chains and Pricing Dynamics

Trade policies introduced in recent years have led to a recalibration of supply chains for enzyme preparations, monoclonal and polyclonal antibodies, and specialized reagents. Tariffs on imported raw materials have placed upward pressure on production costs, compelling manufacturers to explore alternative sourcing strategies and to evaluate localized manufacturing hubs. As a result, many industry participants are reevaluating long-standing supplier relationships to mitigate exposure to import levies and to preserve competitive pricing without compromising quality.

These tariff-related challenges have also prompted collaborative efforts between reagent producers and contract manufacturing organizations to establish resilient supply frameworks. By diversifying procurement across multiple regions and negotiating preferential trade agreements, companies are striving to alleviate cost burdens and maintain consistent delivery schedules for diagnostic laboratories. The cumulative impact of these measures is fostering a more agile and regionally balanced ecosystem, one capable of adapting to ongoing policy shifts and ensuring the uninterrupted availability of critical blood typing intermediates.

Deriving Key Segmentation Insights by Product Type Application End User and Distribution Channel Revealing Strategic Market Pathways

Analyzing market behavior through the lens of product type segmentation reveals nuanced opportunities for specialization and value differentiation. Demand for glycosidase and proteolytic enzymes remains strong, driven by their essential role in antigen modification protocols. At the same time, the growth of monoclonal antibodies, particularly IgA, IgG, and IgM isotypes, underscores an industry-wide shift toward high-purity reagents with consistent performance. Manufacturers of goat, rabbit, and sheep derived polyclonal antibodies are also refining their immunoglobulin extraction processes to meet stringent quality expectations, while suppliers of dry, solution, and suspension reagents are enhancing stability and shelf life to support extended logistics cycles.

When viewed through application segmentation, forward and reverse ABO typing continue to be the backbone of routine immunohematology, while auto control, enzyme-treated, and panel testing modalities are expanding in complexity and clinical significance. Electronic cross matching and serological cross matching workflows are being optimized for faster compatibility assessments, and PCR based and serological Rh typing techniques are offering complementary avenues for rapid patient profiling. End user segmentation offers further granularity: private and public blood banks are investing in centralized automation, whereas hospital associated and independent diagnostic laboratories are integrating multiplexed assays. The division between large hospitals and small to medium facilities is fostering tailored reagent kits that align with varying throughput requirements. Distribution channel analysis indicates a growing reliance on direct sales for bespoke reagent orders, distributors for regional coverage, and online channels-both third party e-commerce platforms and vendor websites-to facilitate on-demand replenishment and visibility into inventory.

Highlighting Key Regional Insights Across Americas Europe Middle East & Africa and Asia Pacific Revealing Growth and Adoption Patterns

In the Americas, established healthcare infrastructures and high adoption of advanced laboratory platforms are driving sustained demand for innovative blood typing intermediates. Well defined reimbursement frameworks and robust clinical trial activities further support the uptake of specialized reagents and automated systems. As a result, industry stakeholders continue to invest in localized R&D initiatives and strategic partnerships with academic medical centers to pioneer next generation immunohematology solutions.

Europe, Middle East & Africa present a landscape shaped by harmonized regulatory standards and diverse market maturity levels. Western Europe’s emphasis on stringent quality certifications coexists with growth opportunities in emerging markets across the Middle East and Africa, where expanding healthcare access and governmental investments in blood safety programs are catalyzing demand. Collaborative programs initiated by pan regional entities are fostering technology transfer and capacity building, strengthening the overall ecosystem for blood typing reagents.

Asia-Pacific exhibits one of the fastest rates of laboratory modernization, fueled by rising per capita healthcare expenditure and expanding research activities. Key markets are witnessing aggressive infrastructure development in both urban centers and tier two cities, creating a broad base for reagent adoption. This dynamic environment is encouraging manufacturers to establish regional production facilities and forge relationships with local distributors to navigate complex import regulations and to ensure timely product availability.

Examining How Leading Companies Harness Strategic Collaborations Product Innovation and Quality Assurance to Dominate the Blood Typing Intermediates Market

Leading companies in the blood typing intermediates market are leveraging strategic collaborations with diagnostic instrument manufacturers and healthcare institutions to strengthen their product portfolios. Through co-development agreements, these organizations are integrating proprietary enzyme formulations and monoclonal antibody panels into automated workstations, thereby enhancing assay throughput and reducing manual intervention. Furthermore, a focus on vertical integration-spanning from raw material sourcing to final product distribution-has enabled key players to maintain stringent quality controls while optimizing cost structures.

In addition, continuous investment in quality management systems and accreditation under international standards has bolstered market credibility and facilitated entry into highly regulated markets. Emerging players are carving niches by specializing in novel antigen-specific reagents or by offering customizable reagent kits for specialized applications. Strategic mergers and strategic alliances have also served to expand geographical reach, enabling companies to tap into underserved regions and to scale production capacity in response to evolving clinical demands.

Actionable Recommendations Guiding Industry Leaders to Capitalize on Emerging Opportunities in Blood Typing Intermediates Innovation and Supply Chain Resilience

Industry leaders are encouraged to prioritize the optimization of enzyme and antibody formulations through advanced screening and engineering techniques. By adopting high throughput screening platforms and next generation sequencing for epitope mapping, organizations can accelerate the development of reagents with enhanced specificity and stability. Concurrently, investing in digital integration-such as laboratory information management systems that interface with automated analyzers-can streamline workflows and minimize manual errors.

Regulatory readiness should be addressed proactively by establishing dedicated compliance teams that engage with policymakers and standards organizations. This approach not only accelerates time to market but also ensures that product development aligns with evolving safety guidelines. Supply chain resilience can be fortified through geographic diversification of raw material procurement and by forging strategic partnerships with contract manufacturers in key regions. Finally, fostering collaborative relationships with clinical laboratories, academic researchers, and end users will yield valuable feedback loops that inform product refinement and drive sustained competitive advantage.

In-Depth Research Methodology Detailing Multi-Source Data Collection Analysis and Validation Techniques Underpinning This Market Study

This study employs a rigorous multi-step research methodology, beginning with comprehensive secondary research that sources information from peer reviewed journals, regulatory filings, company disclosures, and public domain data. This foundation is bolstered by primary research, which includes in depth interviews with key opinion leaders, senior executives in manufacturing, procurement heads at clinical laboratories, and technical experts in immunohematology.

Data triangulation is achieved by cross validating insights from secondary sources with primary interview findings and proprietary databases. Advanced analytical techniques are then applied to identify trends, correlations, and strategic inflection points. Quality assurance protocols, including peer reviews and data consistency checks, ensure that the study’s conclusions rest on a solid empirical basis. The final report synthesizes these elements into cohesive narratives, detailed segmentation analyses, and strategic recommendations, offering stakeholders a robust framework for decision making.

Comprehensive Conclusion Synthesizing Critical Technological Advances Regulatory Dynamics and Market Segmentation Trends in Blood Typing Intermediates

Synthesizing the key takeaways, it is evident that blood typing intermediates occupy a pivotal role in modern healthcare diagnostics, as technological advances, regulatory evolution, and dynamic trade policies converge to reshape the landscape. Innovations in enzyme optimization and monoclonal antibody engineering are driving finer resolution in antigen detection, while heightened regulatory standards and tariff adjustments are influencing supply chain strategies and cost structures. Segmentation insights underscore differentiated growth pathways across product categories, application areas, end user segments, and distribution channels, pointing to targeted opportunities for market participants.

Regionally, mature markets continue to demand high precision reagents, whereas emerging regions are rapidly transforming their infrastructure to adopt advanced immunohematology solutions. Leading companies are capitalizing on strategic collaborations, quality excellence, and vertical integration, thereby setting a benchmark for competitive performance. By implementing the actionable recommendations outlined in this report-ranging from innovation acceleration to supply chain diversification-industry stakeholders can effectively navigate an evolving environment and position themselves for sustained success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Product Type
    • Product Type
      • Enzymes
        • Glycosidase Enzymes
        • Proteolytic Enzymes
      • Monoclonal Antibodies
        • Iga
        • Igg
        • Igm
      • Polyclonal Antibodies
        • Goat Derived
        • Rabbit Derived
        • Sheep Derived
      • Reagents
        • Dry Reagents
        • Solution Reagents
        • Suspension Reagents
  • Application
    • Application
      • Abo Typing
        • Forward Typing
        • Reverse Typing
      • Antibody Screening And Identification
        • Auto Control
        • Enzyme Treated
        • Panel Testing
      • Cross Matching
        • Electronic Cross Matching
        • Serological Cross Matching
      • Rh Typing
        • Pcr Based Rh Typing
        • Serological Rh Typing
  • End User
    • Blood Banks
      • Private Blood Banks
      • Public Blood Banks
    • Diagnostic Laboratories
      • Hospital Associated Labs
      • Independent Labs
    • Hospitals
      • Large Hospitals
      • Small And Medium Hospitals
    • Research Institutes
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online Channels
      • Third Party E Commerce
      • Vendor Website
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Ortho Clinical Diagnostics, Inc.
  • Grifols, S.A.
  • Immucor, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • DiaMed GmbH
  • Quotient Limited
  • Merck KGaA
  • Lorne Laboratories Limited
  • Helena Biosciences Europe Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of monoclonal antibody fragments in blood typing intermediate production to enhance specificity and yield
5.2. Integration of continuous flow bioprocessing technologies for scalable blood typing intermediate manufacturing workflows
5.3. Development of recombinant antigen panels for multiplexed blood type screening and rapid diagnostic accuracy improvements
5.4. Use of CRISPR gene editing for tailored antigen expression in blood typing intermediate research and development
5.5. Shift toward synthetic peptide-based reagents to reduce reliance on animal-derived blood typing intermediates
5.6. Emergence of AI-driven data analytics for optimizing formulation and stability of blood typing reagents
5.7. Regulatory harmonization efforts across regions to streamline approval of novel blood typing intermediate compounds
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Typing Intermediates Market, by Product Type
8.1. Introduction
8.2. Product Type
8.2.1. Enzymes
8.2.1.1. Glycosidase Enzymes
8.2.1.2. Proteolytic Enzymes
8.2.2. Monoclonal Antibodies
8.2.2.1. Iga
8.2.2.2. Igg
8.2.2.3. Igm
8.2.3. Polyclonal Antibodies
8.2.3.1. Goat Derived
8.2.3.2. Rabbit Derived
8.2.3.3. Sheep Derived
8.2.4. Reagents
8.2.4.1. Dry Reagents
8.2.4.2. Solution Reagents
8.2.4.3. Suspension Reagents
9. Blood Typing Intermediates Market, by Application
9.1. Introduction
9.2. Application
9.2.1. Abo Typing
9.2.1.1. Forward Typing
9.2.1.2. Reverse Typing
9.2.2. Antibody Screening And Identification
9.2.2.1. Auto Control
9.2.2.2. Enzyme Treated
9.2.2.3. Panel Testing
9.2.3. Cross Matching
9.2.3.1. Electronic Cross Matching
9.2.3.2. Serological Cross Matching
9.2.4. Rh Typing
9.2.4.1. Pcr Based Rh Typing
9.2.4.2. Serological Rh Typing
10. Blood Typing Intermediates Market, by End User
10.1. Introduction
10.2. Blood Banks
10.2.1. Private Blood Banks
10.2.2. Public Blood Banks
10.3. Diagnostic Laboratories
10.3.1. Hospital Associated Labs
10.3.2. Independent Labs
10.4. Hospitals
10.4.1. Large Hospitals
10.4.2. Small And Medium Hospitals
10.5. Research Institutes
11. Blood Typing Intermediates Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Channels
11.4.1. Third Party E Commerce
11.4.2. Vendor Website
12. Americas Blood Typing Intermediates Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Typing Intermediates Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Typing Intermediates Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ortho Clinical Diagnostics, Inc.
15.3.2. Grifols, S.A.
15.3.3. Immucor, Inc.
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. DiaMed GmbH
15.3.7. Quotient Limited
15.3.8. Merck KGaA
15.3.9. Lorne Laboratories Limited
15.3.10. Helena Biosciences Europe Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD TYPING INTERMEDIATES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD TYPING INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD TYPING INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOOD TYPING INTERMEDIATES MARKET: RESEARCHAI
FIGURE 24. BLOOD TYPING INTERMEDIATES MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOOD TYPING INTERMEDIATES MARKET: RESEARCHCONTACTS
FIGURE 26. BLOOD TYPING INTERMEDIATES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD TYPING INTERMEDIATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY GLYCOSIDASE ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY GLYCOSIDASE ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY GOAT DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY GOAT DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RABBIT DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RABBIT DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SHEEP DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SHEEP DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DRY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DRY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SOLUTION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SOLUTION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SUSPENSION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SUSPENSION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY FORWARD TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY FORWARD TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REVERSE TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REVERSE TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY AUTO CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY AUTO CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYME TREATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYME TREATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PANEL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PANEL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ELECTRONIC CROSS MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ELECTRONIC CROSS MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SEROLOGICAL CROSS MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SEROLOGICAL CROSS MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PCR BASED RH TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PCR BASED RH TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SEROLOGICAL RH TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SEROLOGICAL RH TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITAL ASSOCIATED LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITAL ASSOCIATED LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SMALL AND MEDIUM HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY SMALL AND MEDIUM HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY THIRD PARTY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY THIRD PARTY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY VENDOR WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY VENDOR WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BLOOD TYPING INTERMEDIATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BLOOD TYPING INTERMEDIATES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 216. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 217. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 218. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 219. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 220. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 221. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 222. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 223. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 228. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 229. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 232. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 233. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 234. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 235. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 238. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 239. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 240. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 241. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 246. CANADA BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 271. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ABO TYPING, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY ANTIBODY SCREENING AND IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY CROSS MATCHING, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY RH TYPING, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY BLOOD BANKS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL BLOOD TYPING INTERMEDIATES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Typing Intermediates market report include:
  • Ortho Clinical Diagnostics, Inc.
  • Grifols, S.A.
  • Immucor, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • DiaMed GmbH
  • Quotient Limited
  • Merck KGaA
  • Lorne Laboratories Limited
  • Helena Biosciences Europe Ltd.

Related Topics

Related Reports

Blood Typing Reagent Market by Product Type (Lectin, Monoclonal Antibody, Polyclonal Antibody), Technology (Agglutination, Enzyme Linked Immunosorbent Assay, Flow Cytometry), End User, Sample Type - Global Forecast 2025-2030 - Product Image

Blood Typing Reagent Market by Product Type (Lectin, Monoclonal Antibody, Polyclonal Antibody), Technology (Agglutination, Enzyme Linked Immunosorbent Assay, Flow Cytometry), End User, Sample Type - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Blood Typing Market Size, Share & Trends Analysis Report by Product & Services (Instruments, Reagents & Consumables), Test (Antibody Screening), Technique, End Use, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Blood Typing Market Size, Share & Trends Analysis Report by Product & Services (Instruments, Reagents & Consumables), Test (Antibody Screening), Technique, End Use, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Blood Group Typing Market by Product Type (Instruments, Reagents, Software & Services), Technology (Flow Cytometry, Gel Centrifugation, Microplate Agglutination), End User, Application - Global Forecast 2025-2030 - Product Image

Blood Group Typing Market by Product Type (Instruments, Reagents, Software & Services), Technology (Flow Cytometry, Gel Centrifugation, Microplate Agglutination), End User, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Blood Group Typing Market Report 2025 - Product Image

Blood Group Typing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User - Product Image

Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • Report
  • 112 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.